Skip to main content

LifeMap to Offer ProSpec-Tany TechnoGene Products

NEW YORK (GenomeWeb News) – LifeMap Sciences today announced an exclusive distribution deal with ProSpec-Tany TechnoGene to offer more than 1,000 recombinant proteins and antibodies.

LifeMap, a subsidiary of BioTime, will offer the products at the start of 2013. Many of the proteins and antibodies covered by the deal are related to stem cell research, such as growth factors, signaling molecules, differentiation factors, hormones, cytokines, and chemokines, it said, adding that ProSpec's products complement the research product lines of BioTime offered through the LifeMap BioReagents portal.

ProSpec manufactures recombinant proteins and is based in Rehovet, Israel.

LifeMap is the principal marketing and sales arm of BioTime's cell-based products and related reagents for use in academia, research hospitals, and biotech and pharmaceutical firms.

LifeMap has an exclusive license to market the GeneCards and MalaCards databases, and it will soon add links to the ProSpec products in those databases as well as its own LifeMap Discovery database for biomedical and stem cell research, which is anticipated to launch later this year.

"This agreement represents a significant step for our LifeMap BioReagents portal, enabling us to place high quality recombinant proteins in the hands of our research community user base, and increasing our product portfolio and brand awareness," Yaron Guan-Golan, head of marketing for LifeMap Sciences, said in a statement.

Financial and other terms of the deal were not disclosed.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.